NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it expects to file for a refund of taxes paid for the 2004 calendar year, which would provide the company with $623,000 in the first quarter of 2009.

The South Easton, Mass.-based firm said that under the recently enacted American Recovery and Reinvestment Act, small businesses are eligible to claim the five-year carry back of 2008 net operating losses. Pressure Bio said that it expects to for the refund within the next 90 days.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.